When every second counts…
Instant Access to Overdose Medication
NOS is a special patent-pending plastic cap containing Naloxone in a simple spray atomizer, which snaps directly on top of the opioid prescription bottle.
People die each day from opioid-related drug overdose³
People misuse prescription opioids annually¹
People died from opioid overdoses in 2017²
People had an opioid use disorder in 2016¹
People misused prescription opioids for the first time in 2016¹
Deaths attributed to overdose on commonly prescribed opioids in 2017²
Deaths attributed to overdose on synthetic opioids other than methadone in 2017²
Adolescents started to misuse prescription pain medications in 2017
A person is more likely to die from an accidental opioid overdose than from a motor vehicle crash.⁴
When Every Second Counts
CounterAct has developed a patent-pending, Emergency Nasal Overdose Spray Cap that snaps on top of any bottle of prescription opioid medicine.
The company is awaiting FDA approval prior to marketing, and so all descriptions are provided for reference only. Below is an explanation for its intended use:
In a typical opioid overdose emergency, it takes precious minutes for 911 emergency medical personnel to arrive on scene, administer an opioid counter agent such as Naloxone, then transport the victim to a hospital.
Some non-medical emergency responders may not have an overdose counter agent available, and may require substantially more time to obtain critical intervention.
The CounterAct Cap has an emergency opioid counter-agent nasal spray dispenser under its safety cap. No medical training is necessary to use the device.
In just SECONDS – not minutes, anyone who discovers a semi-conscious, or unconscious overdose victim can use CounterAct to instantly administer an emergency dosage of counter agent drug.
Call 911, then administer the CounterAct spray. Inform the Emergency personnel immediately upon arrival and inform them how long since the victim received the counter agent.
In this article, Todd Pizitz, PhD, and Donald Mealing, both Co-Founders of CounterAct, discuss the ongoing opioid crisis in the US and the current use of the opioid reversal medication naxalone, and introduce the CounterAct device for naxalone home use. In the US in...
FDA Accepts CounterAct Proposal to Develop A New Opioid Overdose Spray Device that Fits Patient's Standard Opioid Prescription Pill Bottles. In September, 2018 CounterAct received a positive response from the United States Food and Drug Administration (FDA), enabling...
The United States has more than double the rate of premature overdose deaths of at least 12 other countries, according to a new study. The research, published Monday in the Annals of Internal Medicine, says that there were an estimated 63,632 drug overdose deaths in...
The nation’s opioid epidemic claimed more than 33,000 lives in 2015, but that figure would have been even higher if it wasn’t for the life-saving opioid overdose antidote naloxone. For more than 40 years, naloxone has been used to reverse the effects of opioid...
Sources: 1 2016 National Survey on Drug Use and Health, 2 Mortality in the United States, 2016 NCHS Data Brief No. 293, December 2017, 3 CEA Report: The underestimated cost of the opioid crisis, 2017, 3 National Center for Health Statistics 2017 Final Data for Drug Overdose Deaths, 4 National Safety Council, January 2019